Arthur M. Blank Hospital, INC.

Arthur M. Blank Hospital, INC. was paid $116.52M by Medicaid between Mar 2018 and Dec 2024, across 360 billing codes. Its largest line is 99285, emergency room visit (most serious) — 34% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	2,528	$413K
2019	10,669	$888K
2020	44,806	$6.78M
2021	118,678	$19.52M
2022	195,499	$36.83M
2023	192,847	$32.79M
2024incomplete	128,638	$19.29M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	34%	32,897	31,809	$39.85M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	18%	34,875	34,211	$20.92M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	15%	47,962	46,683	$17.21M
70551	Magnetic resonance imaging, brain; without contrast material	1.9%	1,961	1,945	$2.17M
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	1.8%	649	489	$2.11M
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	1.6%	289	271	$1.91M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.3%	3,026	2,240	$1.52M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	1.2%	753	747	$1.34M
95810	Polysomnography; sleep staging with 4 or more additional parameters	1.0%	631	621	$1.22M
J3490	Unclassified drugs	<1%	23,204	16,921	$1.14M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	<1%	6,981	6,526	$1.08M
76825		<1%	924	915	$1.05M

348 more codes

42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	695	$997K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	789	$990K
95782		<1%	473	$928K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	396	$868K
74230		<1%	911	$833K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	312	$773K
87799		<1%	2,150	$698K
93325		<1%	3,068	$698K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	6,586	$696K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	6,661	$559K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	498	$531K
96361	Intravenous infusion, hydration; each additional hour	<1%	6,866	$493K
92611		<1%	920	$400K
71046	Radiologic examination, chest; 2 views	<1%	9,697	$397K
76770		<1%	1,259	$370K
70450	Computed tomography, head or brain; without contrast material	<1%	2,188	$367K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	255	$358K
93975		<1%	1,510	$332K
J2704	Injection, propofol, 10 mg	<1%	13,787	$310K
70543		<1%	129	$309K
74183		<1%	148	$304K
G0378	Hospital observation service, per hour	<1%	1,351	$301K
99214	Doctor's office visit, returning patient (more involved)	<1%	1,649	$300K
96415		<1%	343	$292K
80053	Comprehensive metabolic panel	<1%	25,101	$288K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	34,378	$282K
86920		<1%	718	$281K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	1,424	$266K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	3,641	$257K
37241		<1%	26	$246K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	6,061	$243K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	655	$238K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	5,906	$231K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	6,289	$227K
36430		<1%	444	$226K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	2,065	$225K
93321		<1%	1,034	$222K
94776		<1%	402	$216K
96375	Therapeutic injection; each additional sequential IV push	<1%	3,529	$212K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	4,221	$205K
75561		<1%	81	$202K
76827		<1%	942	$199K
96367		<1%	1,203	$191K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	253	$187K
96409		<1%	686	$176K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	150	$170K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	298	$166K
74240		<1%	271	$164K
74019		<1%	3,761	$155K
93308		<1%	302	$145K
76536		<1%	715	$143K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	3,304	$137K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	1,505	$135K
76886		<1%	318	$135K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	944	$133K
71555		<1%	50	$131K
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	1,332	$120K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	2,663	$118K
72197		<1%	57	$117K
93304		<1%	200	$114K
87507		<1%	862	$106K
93320		<1%	439	$105K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	4,566	$105K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	771	$101K
49591		<1%	50	$100K
99215	Doctor's office visit, returning patient (complex)	<1%	456	$96K
87086	Culture, bacterial; quantitative colony count, urine	<1%	10,540	$90K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	1,600	$87K
95812		<1%	167	$81K
74018		<1%	1,149	$81K
76870		<1%	554	$76K
70486		<1%	170	$76K
87581		<1%	6,644	$71K
44970		<1%	12	$71K
87486		<1%	6,639	$71K
92567		<1%	595	$70K
82728		<1%	4,003	$70K
71045	Radiologic examination, chest; single view	<1%	1,501	$70K
86850		<1%	2,168	$67K
72170		<1%	1,293	$66K
87497		<1%	1,207	$66K
75565		<1%	206	$65K
97162		<1%	465	$60K
92587		<1%	634	$58K
86833		<1%	441	$56K
86832		<1%	441	$55K
99203	Doctor's office visit, new patient (routine)	<1%	219	$54K
87040		<1%	5,659	$53K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	2,383	$51K
86828		<1%	471	$49K
93017		<1%	40	$48K
80197		<1%	2,500	$46K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	288	$45K
70360		<1%	461	$45K
86360		<1%	801	$44K
83880		<1%	1,252	$44K
73590		<1%	1,259	$43K
86140		<1%	9,723	$41K
73610		<1%	1,472	$41K
51701		<1%	2,528	$41K
94644		<1%	2,673	$40K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	7,129	$39K
73630		<1%	1,384	$39K
86901		<1%	2,409	$38K
75573		<1%	12	$38K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	24	$37K
72040		<1%	1,029	$37K
96411		<1%	98	$36K
85045		<1%	7,647	$36K
85246		<1%	1,187	$35K
73552		<1%	637	$34K
82784		<1%	1,621	$34K
84443	Thyroid stimulating hormone (TSH)	<1%	1,951	$33K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	13,930	$33K
73560		<1%	425	$32K
80048	Basic metabolic panel (calcium, ionized)	<1%	4,783	$30K
85576		<1%	474	$29K
93886		<1%	39	$28K
88185		<1%	80	$28K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	9,894	$27K
83970		<1%	479	$26K
87077		<1%	2,933	$26K
83550		<1%	2,287	$25K
85027		<1%	3,390	$25K
92018		<1%	31	$25K
73070		<1%	959	$23K
85397		<1%	833	$23K
76881		<1%	506	$23K
73130		<1%	939	$22K
86357		<1%	802	$22K
86355		<1%	800	$22K
87186		<1%	2,429	$22K
83020		<1%	1,743	$22K
86359		<1%	1,299	$22K
94668		<1%	148	$22K
83735		<1%	2,588	$22K
94775		<1%	187	$21K
73090		<1%	1,545	$21K
83540		<1%	2,477	$21K
85240		<1%	883	$21K
80069		<1%	1,912	$21K
85730		<1%	2,987	$20K
72100		<1%	375	$19K
83690		<1%	4,236	$19K
82570		<1%	2,772	$19K
J7030	Infusion, normal saline solution , 1000 cc	<1%	10,020	$18K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	25	$18K
86160		<1%	649	$18K
82330		<1%	3,179	$18K
88342		<1%	561	$18K
96450		<1%	44	$17K
88307		<1%	283	$17K
80061	Lipid panel	<1%	963	$17K
73110		<1%	709	$17K
D7140	Extraction, erupted tooth or exposed root	<1%	12	$17K
54161		<1%	26	$16K
85652		<1%	6,002	$16K
81001		<1%	8,065	$15K
85245		<1%	499	$15K
73562		<1%	852	$15K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	2,831	$15K
42830		<1%	14	$14K
82977		<1%	2,301	$14K
83520		<1%	422	$14K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	1,076	$14K
72081		<1%	64	$14K
J1170	Injection, hydromorphone, up to 4 mg	<1%	3,904	$13K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	13,452	$13K
87070		<1%	1,759	$13K
85610		<1%	3,060	$13K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	11,644	$13K
84439		<1%	1,334	$13K
83615		<1%	2,076	$13K
92652		<1%	12	$13K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	657	$13K
82803		<1%	2,796	$12K
88304		<1%	717	$12K
85384		<1%	1,243	$12K
81003		<1%	8,919	$12K
83036	Hemoglobin; glycosylated (A1C)	<1%	1,170	$12K
J0690	Injection, cefazolin sodium, 500 mg	<1%	4,436	$11K
81025		<1%	3,629	$11K
96376		<1%	252	$11K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	198	$11K
92579		<1%	159	$11K
86356		<1%	124	$11K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	1,079	$11K
76010		<1%	212	$10K
86900		<1%	2,409	$10K
86665		<1%	274	$10K
12011		<1%	829	$10K
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	3,112	$10K
86480		<1%	128	$10K
67311		<1%	12	$10K
84156		<1%	2,046	$10K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	335	$9K
J3473	Injection, hyaluronidase, recombinant, 1 usp unit	<1%	37	$9K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	1,110	$9K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	2,670	$9K
84100		<1%	1,621	$9K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	1,049	$9K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,423	$9K
J9370	Vincristine sulfate, 1 mg	<1%	614	$8K
93296		<1%	57	$8K
82248		<1%	1,493	$8K
73140		<1%	450	$8K
86003		<1%	45	$8K
J7999	Compounded drug, not otherwise classified	<1%	1,057	$7K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	1,256	$7K
D9420		<1%	105	$7K
70491		<1%	12	$7K
80143		<1%	959	$7K
94680		<1%	60	$7K
73060		<1%	211	$7K
84703		<1%	1,639	$7K
73030		<1%	289	$6K
88184		<1%	109	$6K
85379		<1%	627	$6K
94645		<1%	381	$6K
J1815	Injection, insulin, per 5 units	<1%	250	$6K
86902		<1%	370	$6K
97161		<1%	40	$6K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	143	$6K
80179		<1%	871	$6K
86256		<1%	368	$5K
86664		<1%	328	$5K
69210		<1%	38	$5K
90686		<1%	1,134	$5K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	12,861	$5K
82247		<1%	987	$5K
87340		<1%	652	$5K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	158	$5K
82948		<1%	1,601	$5K
82550		<1%	1,093	$5K
85999		<1%	528	$5K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	492	$4K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	1,694	$4K
87205		<1%	1,685	$4K
85660		<1%	618	$4K
84145		<1%	252	$4K
99204	Doctor's office visit, new patient (more involved)	<1%	13	$4K
86663		<1%	256	$4K
12001		<1%	416	$3K
82077		<1%	623	$3K
S5571	Insulin delivery device, disposable pen (including insulin); 3 ml size	<1%	147	$3K
76641		<1%	13	$3K
86706		<1%	493	$3K
85732		<1%	190	$3K
70487		<1%	14	$3K
84484		<1%	412	$3K
94660		<1%	66	$3K
82947		<1%	3,240	$3K
85670		<1%	354	$3K
J7050	Infusion, normal saline solution, 250 cc	<1%	2,464	$3K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	792	$3K
J9255	Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg	<1%	68	$3K
84132		<1%	2,695	$2K
97166		<1%	13	$2K
J0290	Injection, ampicillin sodium, 500 mg	<1%	1,180	$2K
84295		<1%	2,693	$2K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	643	$2K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	3,260	$2K
D1120	Dental cleaning, child	<1%	13	$2K
86317		<1%	31	$2K
J1644	Injection, heparin sodium, per 1000 units	<1%	1,053	$2K
82043		<1%	280	$2K
76942		<1%	47	$2K
86039		<1%	170	$2K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	441	$2K
82820		<1%	300	$2K
86592		<1%	740	$2K
83050		<1%	250	$2K
72070		<1%	51	$2K
85014		<1%	3,008	$2K
82810		<1%	274	$2K
73000		<1%	83	$2K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	14	$2K
77072		<1%	12	$2K
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	629	$1K
88313		<1%	24	$1K
85018		<1%	1,170	$1K
87075		<1%	103	$1K
89051		<1%	370	$1K
83516		<1%	65	$1K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	1,099	$1K
80195		<1%	63	$1K
82785		<1%	48	$1K
J9260	Injection, methotrexate sodium, 50 mg	<1%	118	$1K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	324	$1K
29105		<1%	37	$1K
95700		<1%	26	$1K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	562	$936.27
S0030	Injection, metronidazole, 500 mg	<1%	54	$879.21
J1756	Injection, iron sucrose, 1 mg	<1%	16	$840.59
82375		<1%	239	$795.30
82607		<1%	45	$784.74
86364		<1%	78	$763.60
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	13	$762.03
96368		<1%	24	$723.63
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	453	$695.65
S0077	Injection, clindamycin phosphate, 300 mg	<1%	161	$695.20
85347		<1%	237	$685.61
83001		<1%	27	$679.90
25565		<1%	12	$593.36
82670		<1%	15	$589.80
82610		<1%	36	$573.90
90715		<1%	38	$556.91
82150		<1%	133	$542.85
87081		<1%	28	$512.60
84403		<1%	14	$508.62
84402		<1%	14	$501.48
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	58	$451.68
87102		<1%	40	$450.23
86644		<1%	29	$409.25
88240		<1%	38	$368.50
83002		<1%	14	$364.84
86645		<1%	15	$355.65
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	49	$340.50
J1836	Injection, metronidazole, 10 mg	<1%	21	$329.63
84146		<1%	12	$327.24
90472	Immunization administration, each additional vaccine (list separately)	<1%	41	$287.59
86376		<1%	14	$286.72
82746		<1%	17	$268.97
86880		<1%	39	$249.16
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	14	$246.47
87206		<1%	28	$234.64
88311		<1%	54	$234.56
84550		<1%	56	$229.18
J3480	Injection, potassium chloride, per 2 meq	<1%	115	$204.96
86704		<1%	14	$203.70
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	42	$179.94
J0694	Injection, cefoxitin sodium, 1 gm	<1%	29	$178.40
J1171	Injection, hydromorphone, 0.1 mg	<1%	22	$159.96
J2060	Injection, lorazepam, 2 mg	<1%	14	$155.38
86803		<1%	14	$145.59
86308		<1%	29	$80.12
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	<1%	12	$57.73
82565		<1%	32	$35.55
82270		<1%	12	$31.65
J1940	Injection, furosemide, up to 20 mg	<1%	12	$2.94
90656		0%	164	$0.00
12002		0%	26	$0.00
10060		0%	13	$0.00
94664		0%	85	$0.00
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	0%	38	$0.00
94667		0%	13	$0.00
24640		0%	13	$0.00
29125		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCARE, MANAGED (MGR, PROVIDER ENROLLMENT)